Toward the discovery of small molecule PTP1B inhibitors for the treatment of metabolic diseases

Drug Development Research

Volumn 67, Issue 7, 2006, Pages 559-566

  Nichols, Andrew J ^a   Mashal, Robert D ^a   Balkan, Bork ^b  

^a Alinea Pharmaceuticals Inc   (United States)

^b The Institute for Diabetes Discovery   (United States)

Author keywords

Diabetes; Metabolic diseases; Obesity; PTP1B

Indexed keywords

CARBOXYMETHYL SALICYLATE; DIFLUOROMETHYLPHOSPHONATE; OXALYLAMINOBENZOIC ACID; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG MECHANISM; DRUG STRUCTURE; GENE CONTROL; LIPID DIET; LIPID METABOLISM; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 33845221234     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20122     Document Type: Conference Paper

References (61)

1. Ahima RS, Flier JS. 2000. Leptin. Annu Rev Physiol 62:413-437.
2. Ahmad F, Li PM, Meyerovitch J, Goldstein BJ. 1995. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 270:20503-20508.
3. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699-711.
4. Andersen HS, Olsen OH, Iversen LF, Sorensen AL, Mortensen SB, Christensen MS, Branner S, Hansen TK, Lau JF, Jeppesen L, Moran EJ, Su J, Bakir F, Judge L, Shahbaz M, Collins T, Vo T, Newman MJ, Ripka WC, Moller NP. 2002. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B. J Med Chem 45(20):4443-4459.
5. Barford D, Flint AJ, Tonks NK. 1994. Crystal structure of human protein tyrosine phosphatase 1B. Science 263:1397-1404.
6. Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. 2004. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53:3007-3012.
7. Brown-Shimer S, Johnson KA, Lawrence JB, Johnson C, Bruskin A, Green NR, Hill DE. 1990. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci USA 87:5148-5152.
8. Burke TR Jr, Kole HK, Roller PP. 1994. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem Biophys Res Commun 204:129-134.
9. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. 1996. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161.
10. Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fischer EH, Walsh KA. 1989. Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 86:5252-5256.
11. Chen H, Wertheimer SJ, Lin CH, Katz SL, Amrein KE, Burn P, Quon MJ. 1997. Protein-tyrosine phosphatases PTP1B and syp are modulators of insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. J Biol Chem 272:8026-8031.
12. Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2:497-503.
13. Chernoff J, Schievella AR, Jost CA, Erikson RL, Neel BG. 1990. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 87:2735-2739.
14. Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fischer EH, Krebs EG. 1990. Microinjection of a protein-ryrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA 87:5514-5518.
15. Combs AP, Yue EW, Bower M, Ala PJ, Wayland B, Douty B, Takvorian A, Polam P, Wasserman Z, Zhu W, Crawley ML, Pruitt J, Sparks R, Glass B, Modi D, McLaughlin E, Bostrom L, Li M, Galya L, Blom K, Hillman M, Gonneville L, Reid BG, Wei M, Becker-Pasha M, Klabe R, Huber R, Li Y, Hollis G, Burn TC, Wynn R, Liu P, Metcalf B. 2005. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics. J Med Chem 48:6544-6548.
16. Combs AP, Zhu W, Crawley ML, Glass B, Polam P, Sparks RB, Modi D, Takvorian A, McLaughlin E, Yue EW, Wasserman Z, Bower M, Wei M, Rupar M, Ala PJ, Reid BM, Ellis D, Gonneville L, Emm T, Taylor N, Yeleswaram S, Li Y, Wynn R, Burn TC, Hollis G, Liu PC, Metcalf B. 2006. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic. J Med Chem 49:3774-3789.
17. Cool DE, Tonks NK, Charbonneau H, Fischer EH, Krebs EG. 1990. Expression of a human T-cell protein-tyrosine-phosphatase in baby hamster kidney cells. Proc Natl Acad Sci USA 87:7280-7284.
18. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, Krebs EG. 1989. cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family. Proc Natl Acad Sci USA 86:5257-5261.
19. Desmarais S, Friesen RW, Zamboni R, Ramachandran C. 1999. [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases. Biochem J 337:219-223.
20. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, et al. 2002. A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-812.
21. Echwald SM, Bach H, Vestergaard H, Richelsen B, Kristensen K, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. 2002. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of FTP-1B in vitro. Diabetes 51:1-6.
22. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A. 2001. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in 16 myocytes and Fao hepatoma cells. J Biol Chem 276:10207-10211.
23. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548.
24. Flint AJ, Tiganis T, Barford D, Tonks NK. 1997. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94:1680-1685.
25. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. 1992. The nontransmembrane tyrosine phosphatase HTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68:545-560.
26. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. 1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314.
27. Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T. 2005. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 25:819-829.
28. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, Tiganis T. 2003. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23:2096-2108.
29. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. 2000. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 275:4283-4289.
30. Guan KL, Haun RS, Watson SJ, Geahlen RL, Dixon JE. 1990. Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 87:1501-1505.
31. Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG. 2003. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278:739-744.
32. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. 1997. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883.
33. Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS. 2004. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103:3457-3464.
34. Ibarra-Sanchez MJ, Simoncic PD, Nestel FR, Duplay P, Lapp WS, Tremblay ML. 2000. The T-cell protein tyrosine phosphatase. Semin Immunol 12:379-386.
35. Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, Moller NP. 2002. Structure determination of T cell protein-tyrosine phosphatase. J Biol Chem 277:19982-19990.
36. Jia Z, Barford D, Flint AJ, Tonks NK. 1995. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268:1754-1758.
37. Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, Kroeger PE, White DW, Jirousek MR, Trevillyan JM. 2002. Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol 195:109-118.
38. Kenner KA, Anyanwu E, Olefsky JM, Kusari J. 1996. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271:19810-19816.
39. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-5489.
40. Klupa T, Malecki MT, Pezzolesi M, Ji L, Curtis S, Langefeld CD, Rich SS, Warram JH, Krolewski AS. 2000. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 49:2212-2216.
41. LaMontagne KR, Jr., Flint AJ, Franza BR, Jr., Pandergast AM, Tonks NK. 1998. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. Mol Cell Biol 18:2965-2975.
42. Larsen SD, Barf T, Liljebris C, May PD, Ogg D, O'Sullivan TJ, Palazuk BJ, Schostarez HJ, Stevens FC, Bleasdale JE. 2002. Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1B. J Med Chem 45:598-622.
43. Lee H, Xie L, Luo Y, Lee SY, Lawrence DS, Wang XB, Sotgia F, Lisanti MP, Zhang ZY. 2006. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Biochemistry 45:234-240.
44. Liljebris C, Larsen SD, Ogg D, Palazuk BJ, Bleasdale JE. 2002. Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity. J Med Chem 45:1785-1798.
45. Liu G, Szczepankiewicz BG, Pei Z, Janowick DA, Xin Z, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR. 2003a. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J Med Chem 46:2093-2103.
46. Liu G, Xin Z, Liang H, Abad-Zapatero C, Hajduk PJ, Janowick DA, Szczepankiewicz BG, Pei Z, Hutchins CW, Ballaron SJ, Stashko MA, Lubben TH, Berg CE, Rondinone CM, Trevillyan JM, Jirousek MR. 2003b. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. J Med Chem 46:3437-3440.
47. Lund IK, Hansen JA, Andersen HS, Moller NP, Billestrup N. 2005. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol 34:339-351.
48. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161.
49. Myers MP, Andersen JN, Cheng A, Tremblay ML, Horvath CM, Parisien JP, Salmeen A, Barford D, Tonks NK. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem 276:47771-47774.
50. Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, Haffner SM, Bergman RN, Bowden DW. 2004. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53:3013-3019.
51. Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY. 1997. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc Natl Acad Sci USA 94:13420-13425.
52. Romsicki Y, Kennedy BP, Asante-Appiah E. 2003. Purification and characterization of T cell protein tyrosine phosphatase reveals significant functional homology to protein tyrosine phosphatase-1B. Arch Biochem Biophys 414:40-50.
53. Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY 2001. Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem 276:47311-47319.
54. Spencer-Jones NJ, Wang X, Snieder H, Spector TD, Carter ND, O'Dell SD. 2005. Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 54:3296-3304.
55. Tonks NK. 2003. PTP1B: from the sidelines to the front lines!. FEBS Lett 546:140-148.
56. Tonks NK, Cicirelli MF, Diltz CD, Krebs EG, Fischer EH. 1990. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol Cell Biol 10:458-463.
57. Tonks NK, Diltz CD, Fischer EH. 1988a. Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263:6731-6737.
58. Tonks NK, Diltz CD, Fischer EH. 1988b. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263:6722-6730.
59. You-Ten KE, Muise ES, Itie A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML. 1997. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186:683-693.
60. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG. 2002. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2:489-495.
61. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB. 2004. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279:24844-24851.